Chemical and immunological characterization of oxidative nonenzymatic protein modifications in dialysis fluids

Peritoneal Dialysis International

Volumn 23, Issue 1, 2003, Pages 23-32

  Ruiz, Maria Cristina ^a   Portero Otín, Manuel ^a   Pamplona, Reinald ^a   Requena, Jesús R ^b,d   Prat, Joan ^a   Lafarga, Maria Antonieta ^a   Borràs, Mercè ^c   Bellmunt, Maria Josep ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Hospital Arnau de Villanova   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Aminoguanidine; Free radical production; Glycoxidation; Lipoxidation; Metalcatalyzed oxidation; N carboxymethyllysine; Pyrraline; Semialdehydes

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; ALDEHYDE DERIVATIVE; AMINOGUANIDINE; FREE RADICAL; GLUCOSE DEGRADATION PRODUCT; LYSINE; MALONALDEHYDE; PERITONEAL DIALYSIS FLUID; PLASMA PROTEIN; PROTEIN;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GAS CHROMATOGRAPHY; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN MODIFICATION; STATISTICAL ANALYSIS;

EID: 0037230519     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300103     Document Type: Article

References (36)

1. Davies SJ, Bryan J, Phillips L, Russel GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial transplant 1996; 11:498-506.
2. Ledl F, Schleicher E. New aspects of the Maillard reaction in foods and in the human body. Angew Chem Int Ed Engl 1990; 29:565-94.
3. Miyata T, van Ypersele D, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 1999; 55:389-99.
4. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications - a new perspective on an old paradigm. Diabetes 1999; 48:1-9.
5. Stitt AW, He C, Vlassara H. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Biochem Biophys Res Commun 1999; 256:549-56.
6. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9:41-5.
7. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
8. Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C, Vicaut E. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 1999; 48: 2052-8.
9. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du YS, et al. N(E)-(Carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999; 274: 31740-9.
10. Requena JR, Chao CC, Levine RL, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 2001; 98:69-74.
11. Degenhardt TP, Grass L, Reddy S, Thorpe SR, Diamandis EP, Baynes JW. The serum concentration of the advanced glycation end-product N-E-(carboxymethyl) lysine is increased in uremia. Kidney Int 1997; 52:1064-7.
12. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, et al. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075-83.
13. Madson MA, Feather MS. An improved preparation of 3-deoxy-D-erythro-hexos-2-ulose via the bis(benzoyl-hydrazone) and some related constitutional studies. Carbohydr Res 1981; 94:183-91.
14. Portero-Otin M, Nagaraj RH, Monnier VM. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochim Biophys Acta 1995; 1247:74-80.
15. Pamplona R, Portero-Otin M, Ruiz C, Bellmunt MJ, Requena JR, Thorpe SR, et al. Thyroid status modulates glycoxidative and lipoxidative modification of tissue proteins. Free Radic Biol Med 1999; 27:901-10.
16. Escors D, Camafeita E, Ortego J, Laude H, Enjuanes L. Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol 2001; 75:12228-40.
17. Portero-Otin M, Pamplona R, Bellmunt MJ, Bergua M, Prat J. Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients. Eur J Clin Invest 1997; 27:767-73.
18. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997; 23:361-6.
19. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 1996; 320:855-63.
20. Yamada H, Miyata S, Igaki N, Yatabe H, Miyauchi Y, Ohara T, et al. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction. J Biol Chem 1994; 269:20275-80.
21. Khalifah RG, Todd P, Booth AA, Yang SX, Mott JD, Hudson BG. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies. Biochemistry 1996; 35:4645-54.
22. Fu MX, Wells KK, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and crosslinking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994; 43:676-83.
23. Miyata T, Ueda Y, Shinzato T, Lida Y, Tanaka S, Kurokawa K, et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure - renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996; 7:1198-206.
24. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280: 685-94.
25. Roufail E, Soulis T, Boel E, Cooper ME, Rees S. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine. Diabetologia 1998; 41:1419-25.
26. De Deyn PP, Marescau B, Swartz RD, Hogaerth R, Possemiers I, Lowenthal A. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis. Nephron 1990; 54:307-12.
27. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996; 97:238-43.
28. Nagaraj RH, Portero-Otin M, Monnier VM. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes. Arch Biochem Biophys 1996; 325:152-8.
29. Miyata S, Monnier VM. Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J Clin Invest 1992; 89:1102-12.
30. Nilsson-Thorell CB, Muscalu N, Andren AH, Kjellstrand PT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
31. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19: 325-33.
32. Weiss MF, Erhard P, Kader-Attia FA, Wu YC, Deoreo PB, Araki A, et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 2000; 57:2571-85.
33. Refsgaard HH, Tsai L, Stadtman ER. Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc Natl Acad Sci USA 2000; 97:611-16.
34. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505-10.
35. Cochrane SM, Robinson GB. In vitro glycation of glomerular basement membrane alters its permeability: a possible mechanism in diabetic complications. FEBS Lett 1995; 375:41-4.
36. Li YM, Tan AX, Vlassara H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat Med 1995; 1:1057-61.